373 related articles for article (PubMed ID: 36538077)
21. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus.
Muhammad Yusoff F; Wong KK; Mohd Redzwan N
Autoimmunity; 2020 Feb; 53(1):8-20. PubMed ID: 31771364
[TBL] [Abstract][Full Text] [Related]
22. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
23. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
Yang J; Yang X; Yang J; Li M
J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
[TBL] [Abstract][Full Text] [Related]
24. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
26. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
27. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
28. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
29. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
Xu SP; Li YS
Int J Mol Med; 2018 Dec; 42(6):3220-3230. PubMed ID: 30272314
[TBL] [Abstract][Full Text] [Related]
30. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
31. IL-33 neutralization suppresses lupus disease in lupus-prone mice.
Li P; Lin W; Zheng X
Inflammation; 2014 Jun; 37(3):824-32. PubMed ID: 24398614
[TBL] [Abstract][Full Text] [Related]
32. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis.
Du B; Fan X; Lei F; Zhang S; Li G; Xi X
Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801
[TBL] [Abstract][Full Text] [Related]
33. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation.
Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022
[TBL] [Abstract][Full Text] [Related]
34. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
35. A glance on the role of IL-35 in systemic lupus erythematosus (SLE).
Bahadorian D; Faraj TA; Kheder RK; Najmaldin SK; Haghmorad D; Mollazadeh S; Esmaeili SA
Cytokine; 2024 Apr; 176():156501. PubMed ID: 38290255
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
37. Th subset balance in lupus nephritis.
Miyake K; Akahoshi M; Nakashima H
J Biomed Biotechnol; 2011; 2011():980286. PubMed ID: 21904445
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
Li H; Boulougoura A; Endo Y; Tsokos GC
J Autoimmun; 2022 Oct; 132():102870. PubMed ID: 35872102
[TBL] [Abstract][Full Text] [Related]
39. CD19
Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
[TBL] [Abstract][Full Text] [Related]
40. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
